Centene Q2 revenue beats estimates, lifts 2026 outlook
Centene Q2 revenue beats estimates, lifts 2026 outlook
Overview
U.S. managed care provider's Q2 revenue rose 10% yr/yr, beating analyst expectations
Adjusted diluted EPS for Q2 beat analyst expectations
Company raised 2026 GAAP and adjusted EPS guidance, citing business strength and non-recurring items
Outlook
Centene raises 2026 total revenue guidance to $193.5 bln-$197.5 bln
Company lifts 2026 premium and service revenue outlook to $173.0 bln-$177.0 bln
Centene updates 2026 adj diluted EPS guidance floor to greater than $4.80
Result Drivers
PDP GROWTH & PREMIUM YIELD - Co said revenue growth was driven by higher premium yield and membership growth in the Medicare Prescription Drug Plan business
IMPROVED MEDICAL COST MANAGEMENT - Co said lower health benefits ratio reflected improved pricing, risk transfer, and progress in managing medical costs, especially in Medicaid
COST MANAGEMENT & BUSINESS MIX - Co attributed lower SG&A expense ratio to strong cost management, leveraging expenses over higher revenues, and growth in PDP business, which operates at a lower SG&A expense ratio
Company press release: ID:nPn5Jdj2Pa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $53.58 bln | $47.62 bln (16 Analysts) |
Q2 Adjusted EPS | Beat | $2.51 | $1.09 (20 Analysts) |
Q2 EPS |
| $2.19 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 14 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy."
Wall Street's median 12-month price target for Centene Corp is $69.00, about 7.7% above its July 27 closing price of $64.08
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 10 three months ago
Reuters Recommended Reads
July 27 - Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
July 27 - Ensign Group Q2 profit beats on higher occupancy rates
July 27 - Why El Niño's promise of a quieter hurricane season may not guarantee good news for insurers
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Centene
See all newsU.S. STOCKS ON THE MOVE-Moderna, Insulet, Jack Henry
Health insurers, hospitals rise on lower policy-risk outlook
U.S. STOCKS ON THE MOVE-WW Grainger, Eli Lilly, Super Micro
Health insurers, hospitals rally after sweeping midterm win for Democrats
U.S. STOCKS ON THE MOVE-3M, Qnity Electronics, Wayfair, Duolingo